The largest database of trusted experimental protocols

Gram s crystal violet solution

Manufactured by Merck Group
Sourced in Germany, United States

Gram's crystal violet solution is a laboratory reagent used in the Gram staining procedure. It is a vital component of the Gram staining technique, which is a widely used method for the classification and identification of bacteria based on their cell wall structure. The solution contains the dye crystal violet, which selectively stains the peptidoglycan layer of Gram-positive bacterial cell walls, allowing for their differentiation from Gram-negative bacteria.

Automatically generated - may contain errors

22 protocols using gram s crystal violet solution

1

SARS-CoV-2 Neutralizing Antibody Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A chemiluminescent assay (Liaison SARS-CoV-2 trimeric, Diasorin) was used for Spike IgG quantification. Values higher than 33.8 BAU/mL were considered positive. SARS-CoV-2 neutralizing antibody titer (NT Abs) was determined as previously reported [12 (link),13 (link)]. Briefly, 50 µL of serum in serial fourfold dilution, was placed in two wells of a flat-bottom tissue culture microtiter plate (COSTAR, Corning Incorporated, New York, NY, USA). The same volume of 100 TCID50 of SARS-CoV-2 strain was added, and the plates were incubated at 33 °C in 5% CO2. After 1 h of incubation at 33 °C and 5% CO2, VERO E6 cells were added to each well. After further 72 h of incubation at 33 °C and 5% CO2, the plates were stained with Gram’s crystal violet solution (Merck KGaA, Damstadt, Germany) plus 5% formaldehyde 40% m/v (Carlo ErbaSpA, Arese, Italy) for 30 min. The microtiter plates were then washed under running water. The wells were scored to evaluate the degree of cytopathic effect (CPE) compared to the virus control. A blue staining of the wells indicated the presence of NT Abs. The neutralizing titer was the maximum dilution showing the reduction of 90% of CPE. All the experiments were performed in a BSL3 facility. Values higher or equal to 1:10 serum titer were considered positive, according to our protocol.
+ Open protocol
+ Expand
2

Titration of SARS-CoV-2 Variants Post-Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Titration of SARS-CoV2 variants after treatment were defined according to reported protocol [12 ]. Briefly, 50 μl of plasma sample from each pool bag were diluted in 50 μl (1:2) of respiratory medium in two wells of a flat bottom tissue culture microtiter plate (COSTAR, 13 Corning Incorporated, NY 14831, USA) and titrated up to 1:128 in a serial 1:4 dilution. 3x104 VERO E6 cells [VERO C1008 (Vero 76, clone E6, Vero E6); ATCC® CRL-1586™] in 50 μl were added and incubated at 33 °C 5% CO2. After 72 h plates were scored for cytopathic effect (CPE), stained with Gram’s crystal violet solution (Merck KGaA, 64271 Damstadt, Germany) plus 5% formaldehyde 40 % m/v (Carlo ErbaSpA, Arese (MI), Italy) for 30 min and washed under running water. Blue staining of wells indicated the absence of cytopathic effect. Virus titrations were calculated using Reed-Muench method [13 ]. Every treated bag was tested in duplicate with each variant.
+ Open protocol
+ Expand
3

SARS-CoV-2 Variant Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The titer of each variant’s stock was measured at the 50% tissue culture infectious dose (TCID50) in six replicas in a 96-well flat-bottom tissue-culture microtiter plate. Briefly, logarithmic dilutions of previously stocked virus in presence of 3 × 104 VERO E6 cells were incubated for 72 h at 33 °C in 5% CO2. The cells were observed under a microscope for cytopathic effect development and stained with Gram’s crystal violet solution (Merck KGaA, Darmstadt, Germany) plus 5% v/v formaldehyde 40% m/v (Carlo Erba SpA, Arese, Italy). The value of TCID50 mL−1 was calculated with the Reed–Muench method [9 ]. After virus titration, 50 µL of 100 TCID50 was incubated with 50 µL of serial dilutions (1:10 to 1:640) of the subject’s sera in duplicate in a 96-well flat-bottom tissue-culture microtiter plate. After 1 h incubation at 33 °C in 5% CO2, 3 × 104 VERO E6 cells were added to each well. After 72 h incubation, wells were stained with Gram’s crystal violet solution as previously reported. The neutralizing titer demonstrated the maximum dilution with the reduction of 90% of cytopathic effect. A positive titer was equal to or greater than 1:10 [7 (link),8 (link)].
+ Open protocol
+ Expand
4

Microbial Inhibition Assay Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phosphate buffered saline (PBS), alginate, sulfuric acid, absolute ethanol (99.7%), trichloroacetic acid, sulforhodamine B, acetic acid and tris(hydroxymethyl)aminomethane (TRIS base) were purchased from Sigma-Aldrich® (Darmstadt, Germany). Gram’s crystal violet solution, dimethyl sulfoxide (DMSO), deuterated dimethyl sulfoxide (DMSO-d6), anhydrous chloroform, deuterated chloroform (CDCl3), methanol, ethyl acetate (AcOEt) and calcium chloride were bought from Merck® (Lisboa, Portugal). Dehydroabietic acid was obtained from Wako® (Neuss, Germany) (FUJIFILM Wako Pure Chemical Corporation; CAS RN®: 1740-19-8, Molecular Formula: C20H28O2; Molecular Weight: 300.44). Mueller–Hinton Broth (MHB), Mueller–Hinton agar (MHA), Sabouraud dextrose broth (SDB), Sabouraud dextrose agar (SDA) and tryptic soy broth (TSB) were purchased from Biokar® Diagnostics (Allonne, France).
+ Open protocol
+ Expand
5

Viral Titre Determination Using TCID50

Check if the same lab product or an alternative is used in the 5 most similar protocols
After propagation in a 25 cm2 cell flask (Corning, NY14831, USA), the titre of each variant was defined as the 50 % tissue culture infectious dose (TCID50) in six replicate wells of a 96-well flat-bottomed tissue-culture microtitre plate. Logarithmic dilutions of stock virus were incubated for 72 h in the presence of 3 × 104 VERO E6 at 33 °C in 5 % CO2. Cells were observed by light microscopy for CPE development and stained with Gram's crystal violet solution (Merck KGaA, Darmstadt, Germany) plus 5 % v/v formaldehyde 40 % m/v (Carlo Erba SpA, Arese, Italy). The value of TCID50 mL−1 was calculated with the Reed–Muench method [13] (link).
+ Open protocol
+ Expand
6

Quantifying Biofilm Biomass via Crystal Violet

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the biofilm biomass, the washed biofilms were stained with 200 μl of a 0.1% crystal violet solution (1:4 dilution in DDW of the Gram's crystal violet solution, Merck) for 20 min at room temperature57 (link). The stained biofilms were washed twice with DDW, and after drying the wells, the stain was dissolved in 200 μl of a 33% acetic acid solution, and quantified by reading the OD at 595 nm in the M200 Tecan microplate reader. Different dilutions of the test compounds in the absence of bacteria were used to measure background signals. The percentage biofilm formation was calculated by dividing the OD of treated samples on OD of control samples, multiplied with 100%.
+ Open protocol
+ Expand
7

Quantification of Biofilm Biomass

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the resulting biofilm biomass, the washed biofilms were stained with 200 μl of a 0.1% crystal violet solution (1:4 dilution in DDW of the Gram's crystal violet solution, Merck) for 20 min at room temperature [24 (link)]. Thereafter the biofilms were washed twice with DDW and the stain dissolved in 200 μl of a 33% acetic acid solution. The OD at 595 nm was measured spectrophotometrically using the M200 Tecan microplate reader. Different dilutions of the test compounds in the absence of bacteria were used to measure background signals.
+ Open protocol
+ Expand
8

Evaluating Antimicrobial Activity of AEA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ten μL of control and AEA (50 μg/mL, 2 h)-treated MDRSA CI-M cultures at an OD600nm of 0.3 were inoculated on tryptic soy agar plates (Acumedia, Neogen, Lansing, MI, USA) containing 1.5% gelatin followed by a 24 h incubation at 37 °C. Alternatively, 10 μL of their supernatants were inoculated on these plates. The clearance zone around the inoculation site was detected after staining the plates with 0.1% crystal violet solution prepared from a 0.4% Gram’s crystal violet solution (Merck, EMD Millipore Corporation, Billerica, MA, USA) diluted with DDW. After a 15 min incubation, the plates were washed with DDW, and images were captured using the Bio-Rad ChemiDoc XRS+ Imager system and the Image Lab software.
+ Open protocol
+ Expand
9

Quantifying SARS-CoV-2 Spike IgG and Neutralizing Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemiluminescent assay (Liaison SARS-CoV-2 trimeric, Diasorin, Saluggia, Italy) was used for Spike IgG quantification. Results >33.8 BAU/ml were given as positive. SARS-CoV-2 NT Ab titer was determined as previously reported.6 (link) Briefly, 50 μl of serum in serial fourfold dilution was added to two wells of a flat bottom tissue culture microtiter plate (COSTAR, Corning Incorporated, Corning, NY). The same volume of 100 TCID50 of SARS-CoV-2 strain was added and plates were incubated at 33°C in 5% CO2, according to our local protocol.11 (link) After 1-h incubation at 33°C in 5% CO2, VERO E6 cells were added to each well. After 72 h of incubation at 33°C in 5% CO2 under the same conditions, plates were stained with Gram’s crystal violet solution (Merck KGaA, Darmstadt, Germany) plus 5% formaldehyde 40% m/v (Carlo ErbaSpA, Arese, Italy) for 30 min. Microtiter plates were then washed under running water. Wells were scored to evaluate the degree of cytopathic effect (CPE) compared to the virus control. Blue staining of wells indicated the presence of NT Abs. Neutralizing titer was the maximum dilution with the reduction of 90% of CPE. All the experiments were carried out in BSL3 facility. Results ≥1 : 10 serum titer were considered positive, according to our protocol.13
+ Open protocol
+ Expand
10

Microneutralization Assay for SARS-CoV-2 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 strain G614 and VOCs (Delta and Omicron) were isolated from patients in Pavia and used for microneutralization assay [24 (link), 25 ]. Briefly, 50 μL of the sample, starting from 1:10 in a serial twofold dilution series (up to 1:640), was added to two wells of a flat-bottom tissue-culture microtiter plate (COSTAR, Corning Incorporated), mixed with an equal volume of 100 Tissue Culture Infection Dose 50 (TCID50) of a SARS-CoV-2 strain, previously titrated and incubated at 33°C in 5% CO2. All dilutions were made in Eagle’s minimum essential medium with addition of 1% penicillin, streptomycin, and glutamine and 5 μg/mL of trypsin. After 1 h of incubation at 33 °C in 5% CO2, VERO E6 cells (VERO C1008 (Vero 76, cloneE6, Vero E6); ATCC® CRL-1586™) were added to each well. After 48 h of incubation at 33°C in 5% CO2, wells were stained with Gram’s crystal violet solution (Merck) plus 5% formaldehyde 40% m/v (Carlo ErbaSpA) for 30 min. Microtiter plates were then washed in running water. Wells were scored to evaluate the degree of cytopathic effect (CPE) compared with the virus control. Blue staining of wells indicated the presence of neutralizing antibodies. The neutralizing titer was defined as the maximum dilution giving a reduction of 90% of the CPE. The cut-off for positivity was ≥1:10. Positive and negative controls were included in all test runs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!